Open Access News

News from the open access movement


Thursday, April 03, 2008

Taylor & Francis modifies the terms of its iOpenAccess program

Taylor & Francis has modified the terms of its hybrid journal program, iOpenAccess, which now covers 234 journals.  Formerly, iOA articles were published under a CC-BY-NC-ND license.  Now they will be published under a near-equivalent homegrown license.  Here's the key provision:

For non-commercial purposes users may access, download, copy, display and redistribute documents as well as adapt, translate, text and data mine content contained in documents subject to the following conditions:

  • The authors' moral right to the integrity of their work is not compromised....
  • If document content is copied, downloaded or otherwise reused for non-commercial research and education purposes, a link to the appropriate bibliographic citation (authors, journal, article title, volume, issue, page numbers, DOI and the link to the definitive published version on informaworld) should be maintained. Copyright notices and disclaimers should not be deleted.
  • Use of documents for commercial purposes is prohibited....

Documents posted to PubMed Central are without warranty from Taylor & Francis of any kind, either expressed or implied, including, but not limited to, warranties of merchantability, fitness for a particular purpose, or non-infringement. In no event shall Taylor & Francis be liable for any loss or damage arising out of, or in connection, with the use or performance of this information.

Comments

  • In one respect the new license is even more liberal than the CC-BY-NC-ND license it replaces.  It expressly allows some derivative works.
  • The specific mention of PMC suggests that the new license is designed for articles by NIH-funded authors.  But this is strange for two reasons.  First, not all iOA articles will be written by NIH-funded authors.  Second, not all NIH-funded authors publishing in the relevant journals will choose the iOA option.  The first kind of strangeness is easy to take.  There's no harm in having clauses in a license that only apply to a subset of the licensed articles.  The second kind of strangeness, however, may be a sign that T&F is planning to require its NIH-funded authors to choose the iOA option, and pay a large fee ($3,250), for the right to comply with their prior funding contract.  Is it?  Is it planning to force authors who only want green OA to pay for gold OA?